ClinicalTrials.Veeva

Menu

Retrograde Recanalization of Infrainguinal Arterial Occlusive Disease.

S

Sohag University

Status

Unknown

Conditions

Critical Limb Ischemia

Treatments

Procedure: retrograde access for re-canalization of infra-inguinal arterial occlusive disease

Study type

Interventional

Funder types

Other

Identifiers

NCT04974905
Soh-Med-21-07-22

Details and patient eligibility

About

The spectrum of lower extremity peripheral arterial disease (PAD) ranges from exhibiting no symptoms to limb threatening gangrene. The number of patients living with it is rising steadily owing to increased life expectancy, obesity, diabetes, and tobacco consumption.

Critical limb ischemia (CLI) is the terminal and the most serious stage of PAD in which blood flow to the lower extremity does not meet metabolic demands of the tissues at rest. The diagnosis is mainly clinical and patients are presented with rest pain, minimal tissue loss or frank gangrene.

Revascularization strategies include endovascular procedures and surgical bypass.Endovascular therapy has evolved as an attractive, minimally invasive method of revascularization especially in the more frequently encountered patients with medical and anatomical contraindications to surgical revascularization.

Antegrade approach is the standard approach in infrainguinal arterial occlusive disease,however, failure occurs in about 20% of infrainguinal attempts.Retrograde approach is used as a backup technique in failed cases.

Enrollment

40 estimated patients

Sex

All

Ages

35 to 95 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

patients with;

  1. CLI consistent with Rutherford categories (4-5).
  2. Infrainguinal arterial occlusive disease with a patent distal part of at least one tibial vessel runoff to the foot.

Exclusion criteria

patients with the following conditions will be excluded:

  1. Non-salvageable limbs.
  2. Life threatening infections requiring major amputation.
  3. Ulcers at the area of intended puncture.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

patients with infrainguinal arterial occlusive disease after failed antegrade approach
Other group
Treatment:
Procedure: retrograde access for re-canalization of infra-inguinal arterial occlusive disease

Trial contacts and locations

0

Loading...

Central trial contact

Mostafa A Foda, Msc; Hussein K Hussein, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems